The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP)

Kyriaki Tzogani; Nithyanandan Nagercoil; Robert James Hemmings; Bekkai Samir; Jean Gardette; Pierre Demolis; Tomas Salmonson; Francesco Pignatti

doi:10.1684/ejd.2014.2368

The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP)

European Journal of Dermatology ◽

10.1684/ejd.2014.2368 ◽

2014 ◽

Vol 24 (4) ◽

pp. 457-463 ◽

Cited By ~ 16

Author(s):

Kyriaki Tzogani ◽

Nithyanandan Nagercoil ◽

Robert James Hemmings ◽

Bekkai Samir ◽

Jean Gardette ◽

...

Keyword(s):

Actinic Keratosis ◽

European Medicines Agency ◽

Medicinal Products ◽

Ingenol Mebutate ◽

Scientific Assessment ◽

Human Use

Download Full-text

The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Journal of Dermatological Treatment ◽

10.3109/09546634.2013.789474 ◽

2013 ◽

Vol 25 (5) ◽

pp. 371-374 ◽

Cited By ~ 3

Author(s):

Kyriaki Tzogani ◽

Myrjam Straube ◽

Ute Hoppe ◽

Peter Kiely ◽

Geraldine O’Dea ◽

...

Keyword(s):

Actinic Keratosis ◽

Moderate Intensity ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Aminolaevulinic Acid ◽

The Face ◽

Human Use

Download Full-text

The European Medicines Agency Review of Pazopanib for the Treatment of Advanced Renal Cell Carcinoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-1734 ◽

2011 ◽

Vol 17 (21) ◽

pp. 6608-6614 ◽

Cited By ~ 18

Author(s):

Maria Nieto ◽

Jeanett Borregaard ◽

Jens Ersbøll ◽

George J.A. ten Bosch ◽

Barbara van Zwieten-Boot ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Advanced Renal Cell Carcinoma ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use

Download Full-text

The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

European Journal of Cancer ◽

10.1016/j.ejca.2011.09.018 ◽

2012 ◽

Vol 48 (2) ◽

pp. 237-242 ◽

Cited By ~ 39

Author(s):

Zahra Hanaizi ◽

Barbara van Zwieten-Boot ◽

Gonzalo Calvo ◽

Arantxa Sancho Lopez ◽

Maaike van Dartel ◽

...

Keyword(s):

Metastatic Melanoma ◽

European Medicines Agency ◽

Medicinal Products ◽

Prior Therapy ◽

Scientific Assessment ◽

Human Use

Download Full-text

The European Medicines Agency Review of Eribulin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-3075 ◽

2012 ◽

Vol 18 (17) ◽

pp. 4491-4497 ◽

Cited By ~ 29

Author(s):

Elias Pean ◽

Sigrid Klaar ◽

Eva Gil Berglund ◽

Tomas Salmonson ◽

Jeanett Borregaard ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use

Download Full-text

The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2015-0276 ◽

2015 ◽

Vol 21 (1) ◽

pp. 102-109 ◽

Cited By ~ 17

Author(s):

Iordanis Gravanis ◽

Kyriaki Tzogani ◽

Paula Hennik ◽

Pieter Graeff ◽

Petra Schmitt ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Large Cell ◽

Brentuximab Vedotin ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Large Cell Lymphoma ◽

Human Use

Download Full-text

The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2015-0298 ◽

2016 ◽

Vol 21 (6) ◽

pp. 692-700 ◽

Cited By ~ 24

Author(s):

Maria Nieto ◽

Pierre Demolis ◽

Eliane Béhanzin ◽

Alexandre Moreau ◽

Ian Hudson ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Adult Patients ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use ◽

Acute Myeloid

Download Full-text

The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior Treatment With Sunitinib or a Cytokine: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2014-0177 ◽

2015 ◽

Vol 20 (2) ◽

pp. 196-201 ◽

Cited By ~ 18

Author(s):

Kyriaki Tzogani ◽

Venke Skibeli ◽

Ingunn Westgaard ◽

Marianne Dalhus ◽

Hege Thoresen ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Prior Treatment ◽

Advanced Renal Cell Carcinoma ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use

Download Full-text

The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

European Journal of Cancer ◽

10.1016/j.ejca.2013.01.015 ◽

2013 ◽

Vol 49 (7) ◽

pp. 1654-1661 ◽

Cited By ~ 35

Author(s):

Silvy da Rocha Dias ◽

Tomas Salmonson ◽

Barbara van Zwieten-Boot ◽

Bertil Jonsson ◽

Serena Marchetti ◽

...

Keyword(s):

Metastatic Melanoma ◽

Adult Patients ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use ◽

Braf V600 Mutation

Download Full-text

The European Medicines Agency Review of Pomalidomide in Combination With Low‐Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2014-0073 ◽

2015 ◽

Vol 20 (3) ◽

pp. 329-334 ◽

Cited By ~ 13

Author(s):

Zahra Hanaizi ◽

Beatriz Flores ◽

Robert Hemmings ◽

Jorge Camarero ◽

Arantxa Sancho‐Lopez ◽

...

Keyword(s):

Multiple Myeloma ◽

Low Dose ◽

Adult Patients ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use

Download Full-text

The European Medicines Agency Review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the Treatment of Advanced Gastric Cancer When Given in Combination with Cisplatin: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use (CHMP)

The Oncologist ◽

10.1634/theoncologist.2011-0224 ◽

2011 ◽

Vol 16 (10) ◽

pp. 1451-1457 ◽

Cited By ~ 13

Author(s):

Petra Matt ◽

Barbara Zwieten‐Boot ◽

Gonzalo Calvo Rojas ◽

Hadewych Hofstede ◽

Rocio Garcia‐Carbonero ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

European Medicines Agency ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use

Download Full-text